Literature DB >> 28264185

How Much Accuracy of Interstitial Glucose Measurement Is Enough? Is There a Need for New Evidence?

Norbert Hermanns1,2,3, Dominic Ehrmann1,3, Bernhard Kulzer1,2,3.   

Abstract

This analytical comment discusses what standards are needed for the evaluation of the accuracy of glucose measurement systems continuously measuring glucose in the interstitial fluid. Since accuracy standards for continuous glucose monitoring (CGM)/flash glucose monitoring (FGM) systems are currently based on modeling studies or consensus of experts, we raised the question whether non-inferiority trials evaluating the safety and efficacy of CGM/FGM measurements compared to capillary blood glucose measurement with point-of-care devices could help to establish clarity about the needed accuracy standards of CGM/FGM. Such trials could also support the replacement of capillary blood glucose measurements by modern CGM/FGM systems.

Entities:  

Keywords:  accuracy standards of continuous glucose monitoring systems; blood glucose monitoring; continuous glucose monitoring; flash glucose monitoring

Mesh:

Substances:

Year:  2016        PMID: 28264185      PMCID: PMC5478034          DOI: 10.1177/1932296816677578

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN: 1932-2968


  18 in total

1.  Improved glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring.

Authors:  Dorothee Deiss; Jan Bolinder; Jean-Pierre Riveline; Tadej Battelino; Emanuele Bosi; Nadia Tubiana-Rufi; David Kerr; Moshe Phillip
Journal:  Diabetes Care       Date:  2006-12       Impact factor: 19.112

2.  Comment on "The Performance and Usability of a Factory-Calibrated Flash Glucose Monitoring System" by Bailey et al.

Authors:  Guido Freckmann; Stefan Pleus; Sandra Schlüter; Lutz Heinemann
Journal:  Diabetes Technol Ther       Date:  2016-02-22       Impact factor: 6.118

3.  Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trial.

Authors:  Cornelis A J van Beers; J Hans DeVries; Susanne J Kleijer; Mark M Smits; Petronella H Geelhoed-Duijvestijn; Mark H H Kramer; Michaela Diamant; Frank J Snoek; Erik H Serné
Journal:  Lancet Diabetes Endocrinol       Date:  2016-09-15       Impact factor: 32.069

4.  Do currently available blood glucose monitors meet regulatory standards? 1-day public meeting in Arlington, Virginia.

Authors:  David C Klonoff; Juliet S Reyes
Journal:  J Diabetes Sci Technol       Date:  2013-07-01

5.  Continuous glucose monitoring and intensive treatment of type 1 diabetes.

Authors:  William V Tamborlane; Roy W Beck; Bruce W Bode; Bruce Buckingham; H Peter Chase; Robert Clemons; Rosanna Fiallo-Scharer; Larry A Fox; Lisa K Gilliam; Irl B Hirsch; Elbert S Huang; Craig Kollman; Aaron J Kowalski; Lori Laffel; Jean M Lawrence; Joyce Lee; Nelly Mauras; Michael O'Grady; Katrina J Ruedy; Michael Tansey; Eva Tsalikian; Stuart Weinzimer; Darrell M Wilson; Howard Wolpert; Tim Wysocki; Dongyuan Xing
Journal:  N Engl J Med       Date:  2008-09-08       Impact factor: 91.245

6.  Effect of continuous glucose monitoring on hypoglycemia in type 1 diabetes.

Authors:  Tadej Battelino; Moshe Phillip; Natasa Bratina; Revital Nimri; Per Oskarsson; Jan Bolinder
Journal:  Diabetes Care       Date:  2011-02-19       Impact factor: 19.112

7.  Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data.

Authors:  John C Pickup; Suzanne C Freeman; Alex J Sutton
Journal:  BMJ       Date:  2011-07-07

8.  The Performance and Usability of a Factory-Calibrated Flash Glucose Monitoring System.

Authors:  Timothy Bailey; Bruce W Bode; Mark P Christiansen; Leslie J Klaff; Shridhara Alva
Journal:  Diabetes Technol Ther       Date:  2015-07-14       Impact factor: 6.118

9.  Incremental value of continuous glucose monitoring when starting pump therapy in patients with poorly controlled type 1 diabetes: the RealTrend study.

Authors:  Denis Raccah; Véronique Sulmont; Yves Reznik; Bruno Guerci; Eric Renard; Hélène Hanaire; Nathalie Jeandidier; Marc Nicolino
Journal:  Diabetes Care       Date:  2009-09-18       Impact factor: 19.112

10.  The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial.

Authors:  T Battelino; I Conget; B Olsen; I Schütz-Fuhrmann; E Hommel; R Hoogma; U Schierloh; N Sulli; J Bolinder
Journal:  Diabetologia       Date:  2012-09-11       Impact factor: 10.122

View more
  3 in total

Review 1.  Measures of Accuracy for Continuous Glucose Monitoring and Blood Glucose Monitoring Devices.

Authors:  Guido Freckmann; Stefan Pleus; Mike Grady; Steven Setford; Brian Levy
Journal:  J Diabetes Sci Technol       Date:  2018-11-19

2.  Makes FLASH the difference between the intervention group and the treatment-as-usual group in an evaluation study of a structured education and treatment programme for flash glucose monitoring devices in people with diabetes on intensive insulin therapy: study protocol for a randomised controlled trial.

Authors:  Melanie Schipfer; Carmen Albrecht; Dominic Ehrmann; Thomas Haak; Bernd Kulzer; Norbert Hermanns
Journal:  Trials       Date:  2018-02-05       Impact factor: 2.279

3.  Measurement Performance of Two Continuous Tissue Glucose Monitoring Systems Intended for Replacement of Blood Glucose Monitoring.

Authors:  Guido Freckmann; Manuela Link; Stefan Pleus; Antje Westhoff; Ulrike Kamecke; Cornelia Haug
Journal:  Diabetes Technol Ther       Date:  2018-08       Impact factor: 6.118

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.